Cassava Sciences (SAVA) Short Interest Ratio & Short Volume $14.92 +2.17 (+17.02%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cassava Sciences Short Interest DataCurrent Short Interest16,130,000 sharesPrevious Short Interest13,090,000 sharesChange Vs. Previous Month+23.22%Dollar Volume Sold Short$198.88 millionShort Interest Ratio8.3 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares47,980,000 sharesPercentage of Shares Shorted33.62%Today's Trading Volume3,647,647 sharesAverage Trading Volume4,731,227 sharesToday's Volume Vs. Average77% Short Selling Cassava Sciences ? Sign up to receive the latest short interest report for Cassava Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSAVA Short Interest Over TimeSAVA Days to Cover Over TimeSAVA Percentage of Float Shorted Over Time Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> Cassava Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202416,130,000 shares $198.88 million +23.2%N/A8.3 $12.33 6/30/202413,090,000 shares $161.66 million +3.5%N/A9 $12.35 6/15/202412,650,000 shares $249.46 million +1.7%N/A15.7 $19.72 5/31/202412,440,000 shares $274.05 million -2.8%N/A15 $22.03 5/15/202412,800,000 shares $294.53 million -7.7%N/A15.4 $23.01 4/30/202413,870,000 shares $307.22 million +8.0%N/A17.4 $22.15 Get the Latest News and Ratings for SAVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cassava Sciences and its competitors with MarketBeat's FREE daily newsletter. 4/15/202412,840,000 shares $256.93 million +8.9%N/A17.7 $20.01 3/31/202411,790,000 shares $239.22 million -1.4%N/A17 $20.29 3/15/202411,960,000 shares $254.63 million +5.7%30.5%15.7 $21.29 2/29/202411,320,000 shares $260.13 million -3.7%28.9%11.4 $22.98 2/15/202411,760,000 shares $288.94 million -3.5%30.7%12.3 $24.57 1/31/202412,180,000 shares $291.71 million -8.6%31.8%11.5 $23.95 1/15/202413,330,000 shares $349.78 million -4.0%33.6%10.2 $26.24 12/31/202313,890,000 shares $312.66 million +8.9%35.0%9.2 $22.51 12/15/202312,760,000 shares $268.96 million -7.0%32.2%8.6 $21.08 11/30/202313,720,000 shares $285.79 million -5.8%34.7%11.2 $20.83 11/15/202314,560,000 shares $317.70 million -8.9%36.8%11.3 $21.82 10/31/202315,990,000 shares $322.20 million +14.1%40.6%12.4 $20.15 10/15/202314,020,000 shares $208.34 million -1.3%35.6%13.1 $14.86 9/30/202314,210,000 shares $236.45 million +3.7%36.1%17.2 $16.64 9/15/202313,700,000 shares $265.92 million +2.7%34.8%14.8 $19.41 8/31/202313,340,000 shares $279.74 million +8.8%33.9%14.8 $20.97 8/15/202312,260,000 shares $215.16 million +7.3%31.1%14.9 $17.55 7/31/202311,430,000 shares $251.23 million +2.1%29.0%13.4 $21.98 7/15/202311,200,000 shares $242.26 million +10.5%28.6%13.9 $21.63 6/30/202310,140,000 shares $248.63 million +8.1%25.9%13 $24.52 6/15/20239,380,000 shares $235.16 million -13.2%23.9%14.4 $25.07 5/31/202310,800,000 shares $245.27 million +6.3%27.6%15.2 $22.71 5/15/202310,160,000 shares $269.34 million -7.5%25.9%14.4 $26.51 4/30/202310,980,000 shares $254.96 million -0.6%28.0%14.5 $23.22 4/15/202311,050,000 shares $257.69 million -3.9%28.2%10.1 $23.32 3/31/202311,500,000 shares $277.38 million +9.9%30.0%9.7 $24.12 3/15/202310,460,000 shares $272.48 million -5.0%27.3%7.9 $26.05 2/28/202311,010,000 shares $271.95 million +3.9%28.7%7.9 $24.70 2/15/202310,600,000 shares $279.95 million +7.6%27.6%7.6 $26.41 1/31/20239,850,000 shares $275.80 million -4.6%25.1%6.4 $28.00 1/15/202310,320,000 shares $350.88 million +18.8%26.3%7.3 $34.00 12/30/20228,690,000 shares $256.70 million -1.3%22.1%7 $29.54 12/15/20228,800,000 shares $348.22 million -5.7%22.4%5.6 $39.57 11/30/20229,330,000 shares $324.96 million No Change23.8%4 $34.83Get out of cash before the Fed's next meeting (Ad)"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."Click here now to watch this exclusive interview 11/15/20229,330,000 shares $374.13 million -0.4%23.8%3.7 $40.10 10/31/20229,370,000 shares $341.44 million -2.7%24.9%2.8 $36.44 10/15/20229,630,000 shares $351.11 million -10.7%25.6%2.6 $36.46 9/30/202210,780,000 shares $450.82 million -14.1%N/A2.9 $41.82 9/15/202212,550,000 shares $396.33 million -0.2%N/A3.7 $31.58 8/31/202212,580,000 shares $323.68 million +4.4%N/A5.1 $25.73 8/15/202212,050,000 shares $243.29 million +5.4%N/A5.1 $20.19 7/31/202211,430,000 shares $186.65 million +12.3%N/A7.7 $16.33 7/15/202210,180,000 shares $243.40 million -2.2%N/A8.4 $23.91 6/30/202210,410,000 shares $292.73 million -5.1%N/A7.1 $28.12 6/15/202210,970,000 shares $294.00 million -4.9%N/A6.7 $26.80 5/31/202211,530,000 shares $352.82 million -2.7%30.9%7 $30.60 5/15/202211,850,000 shares $227.99 million +0.9%31.8%7.5 $19.24 4/30/202211,750,000 shares $245.22 million +2.5%31.5%6.9 $20.87 4/15/202211,460,000 shares $300.83 million +7.4%31.5%6.5 $26.25 3/31/202210,670,000 shares $396.28 million -2.4%29.4%6.4 $37.14 3/15/202210,930,000 shares $380.91 million -3.3%30.1%5.1 $34.85 2/28/202211,300,000 shares $480.36 million -5.4%31.1%4.7 $42.51 2/15/202211,950,000 shares $588.18 million -12.1%32.9%4.7 $49.22 1/31/202213,600,000 shares $601.80 million +4.7%37.4%4.4 $44.25 1/15/202212,990,000 shares $595.98 million -4.6%34.8%2.8 $45.88 12/31/202113,610,000 shares $594.76 million +11.7%36.5%2.8 $43.70 12/15/202112,190,000 shares $558.06 million +18.9%N/A2.2 $45.78 11/30/202110,250,000 shares $548.27 million +22.3%27.5%1.7 $53.49 11/15/20218,380,000 shares $507.07 million -26.2%22.5%1 $60.51 10/29/202111,350,000 shares $489.53 million +20.5%30.4%1.3 $43.13 10/15/20219,420,000 shares $468.08 million +7.4%25.3%1.2 $49.69 9/30/20218,770,000 shares $544.44 million -1.2%23.5%1.1 $62.08 9/15/20218,880,000 shares $390.01 million +12.4%23.8%1.1 $43.92 8/31/20217,900,000 shares $449.12 million +46.3%21.2%1.1 $56.85 8/13/20215,400,000 shares $661.88 million +35.0%14.5%1.3 $122.57 7/30/20214,000,000 shares $278.12 million -9.5%10.7%1 $69.53 7/15/20214,420,000 shares $364.34 million +11.6%11.9%1.7 $82.43 6/30/20213,960,000 shares $338.34 million +5.3%10.6%1.8 $85.44 6/15/20213,760,000 shares $271.10 million -0.5%10.1%2 $72.10 5/28/20213,780,000 shares $203.82 million +8.9%10.1%2.1 $53.92 5/14/20213,470,000 shares $131.10 million -7.7%N/A1.9 $37.78 4/30/20213,760,000 shares $178.86 million +3.6%N/A1.2 $47.57 4/15/20213,630,000 shares $129.48 million +5.5%N/A0.6 $35.67 3/31/20213,440,000 shares $151.22 million -5.8%N/A0.5 $43.96 3/15/20213,650,000 shares $195.06 million +24.2%N/A0.5 $53.44 2/26/20212,940,000 shares $149.59 million +12.2%N/A0.4 $50.88 2/12/20212,620,000 shares $126.26 million -56.2%N/A0.4 $48.19 1/29/20215,980,000 shares $111.95 million +9.5%N/A1 $18.72 1/15/20215,460,000 shares $57.22 million +2.1%N/A1.6 $10.48 12/31/20205,350,000 shares $37.50 million +2.9%N/A2 $7.01 12/15/20205,200,000 shares $40.35 million -12.9%N/A1.7 $7.76 11/30/20205,970,000 shares $46.33 million -0.3%N/A0.7 $7.76 11/15/20205,990,000 shares $50.14 million +11.8%N/A0.7 $8.37 10/30/20205,360,000 shares $46.79 million +15.5%N/A0.7 $8.73Get out of cash before the Fed's next meeting (Ad)"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."Click here now to watch this exclusive interview 10/15/20204,640,000 shares $50.99 million -6.8%N/A0.7 $10.99 9/30/20204,980,000 shares $57.32 million +79.1%N/A0.7 $11.51 9/15/20202,780,000 shares $19.52 million -8.0%N/A0.4 $7.02 8/31/20203,020,000 shares $9.48 million +4.5%N/A1.7 $3.14 8/14/20202,890,000 shares $9.77 million -7.1%N/A0.9 $3.38 7/31/20203,110,000 shares $9.86 million -11.1%N/A0.7 $3.17 7/15/20203,500,000 shares $12.78 million +3.2%N/A0.8 $3.65 6/30/20203,390,000 shares $10.44 million +19.4%N/A0.8 $3.08 6/15/20202,840,000 shares $7.30 million -4.4%N/A0.8 $2.57 5/29/20202,970,000 shares $6.36 million +19.8%N/A0.8 $2.14 5/15/20202,480,000 shares $5.26 million +4.2%N/A1.2 $2.12 4/30/20202,380,000 shares $19.02 million +36.0%N/A2.4 $7.99 4/15/20201,750,000 shares $9.63 million +33.6%N/A1.4 $5.50 3/31/20201,310,000 shares $9.33 million +19.3%N/A0.8 $7.12 3/13/20201,098,100 shares $5.28 million -7.7%7.5%1.4 $4.81 2/28/20201,190,000 shares $4.95 million -17.4%8.1%0.2 $4.16 2/14/20201,440,000 shares $7.17 million +2.1%9.8%0.3 $4.98 1/31/20201,410,000 shares $9.07 million -19.0%9.7%0.3 $6.43 1/15/20201,740,000 shares $13.66 million -46.0%11.9%0.4 $7.85 12/31/20193,220,000 shares $23.12 million +41.9%22.1%0.8 $7.18 8/15/20191,768,100 shares $1.94 million +3.2%11.4%8.2 $1.10 SAVA Short Interest - Frequently Asked Questions What is Cassava Sciences' current short interest? Short interest is the volume of Cassava Sciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 16,130,000 shares of SAVA short. Learn More on Cassava Sciences' current short interest. What is a good short interest ratio for Cassava Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SAVA shares currently have a short interest ratio of 8.0. Learn More on Cassava Sciences's short interest ratio. Which institutional investors are shorting Cassava Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cassava Sciences: Concourse Financial Group Securities Inc., and Walleye Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cassava Sciences' short interest increasing or decreasing? Cassava Sciences saw a increase in short interest in July. As of July 15th, there was short interest totaling 16,130,000 shares, an increase of 23.2% from the previous total of 13,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cassava Sciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Cassava Sciences: Verrica Pharmaceuticals Inc. (15.37%), Nature's Sunshine Products, Inc. (1.08%), scPharmaceuticals Inc. (25.94%), Verastem, Inc. (11.19%), Chimerix, Inc. (2.00%), Fortress Biotech, Inc. (9.74%), Amneal Pharmaceuticals, Inc. (4.13%), Protagonist Therapeutics, Inc. (5.56%), Deciphera Pharmaceuticals, Inc. (5.71%), Catalyst Pharmaceuticals, Inc. (5.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Cassava Sciences stock? Short selling SAVA is an investing strategy that aims to generate trading profit from Cassava Sciences as its price is falling. SAVA shares are trading up $2.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cassava Sciences? A short squeeze for Cassava Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SAVA, which in turn drives the price of the stock up even further. How often is Cassava Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SAVA, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Verrica Pharmaceuticals Short Interest Data Nature's Sunshine Products Short Interest Data scPharmaceuticals Short Interest Data Verastem Short Interest Data Chimerix Short Interest Data Fortress Biotech Short Interest Data Amneal Pharmaceuticals Short Interest Data Protagonist Therapeutics Short Interest Data Deciphera Pharmaceuticals Short Interest Data Catalyst Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SAVA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cassava Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.